Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus

Samir K LakhasheRuth M Ruprecht


We sought to test whether vaccine-induced immune responses could protect rhesus macaques (RMs) against upfront heterologous challenges with an R5 simian-human immunodeficiency virus, SHIV-2873Nip. This SHIV strain exhibits many properties of transmitted HIV-1, such as tier 2 phenotype (relatively difficult to neutralize), exclusive CCR5 tropism, and gradual disease progression in infected RMs. Since no human AIDS vaccine recipient is likely to encounter an HIV-1 strain that exactly matches the immunogens, we immunized the RMs with recombinant Env proteins heterologous to the challenge virus. For induction of immune responses against Gag, Tat, and Nef, we explored a strategy of immunization with overlapping synthetic peptides (OSP). The immune responses against Gag and Tat were finally boosted with recombinant proteins. The vaccinees and a group of ten control animals were given five low-dose intrarectal (i.r.) challenges with SHIV-2873Nip. All controls and seven out of eight vaccinees became systemically infected; there was no significant difference in viremia levels of vaccinees vs. controls. Prevention of viremia was observed in one vaccinee which showed strong boosting of virus-specific cellular immunity during virus exposur...Continue Reading


Jun 25, 2002·The Journal of Biological Chemistry·Sandrine OpiErwann P Loret
Feb 13, 2003·Nucleic Acids Research·Rafael A IrizarryTerence P Speed
Jul 5, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ranajit PalMarvin Reitz
Aug 7, 2004·Bioinformatics·Vincent J CareyRobert Gentleman
Jun 24, 2006·Vaccine·Shisong JiangRuth M Ruprecht
Nov 3, 2007·The Journal of Clinical Investigation·Sylvie Le GallBruce D Walker
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
Feb 10, 2009·Journal of Medical Primatology·Robert De RoseStephen J Kent
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
May 14, 2010·Clinical and Vaccine Immunology : CVI·Stanley A Plotkin
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
May 6, 2011·Science Translational Medicine·Norman L LetvinGary J Nabel
May 11, 2011·The Journal of Clinical Investigation·Estibaliz LazaroSylvie Le Gall
Jul 19, 2011·Lancet·Nancy S PadianMyron S Cohen
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Nov 15, 2011·Current Opinion in Virology·Samir K LakhasheRuth M Ruprecht
Mar 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Herman N EisenRichard J Cohen
Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
Apr 20, 2012·Nature Immunology·Andrew J McMichael, Barton F Haynes
May 29, 2012·The Journal of Infectious Diseases·David C MontefioriJerome H Kim
Sep 11, 2012·Nature Medicine·Yoshinori FukazawaLouis J Picker
Dec 25, 2012·Cell Reports·Wei LuJean-Marie Andrieu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

The New England Journal of Medicine
Diane Havlir, Chris Beyrer
The New England Journal of Medicine
Myron S Cohen, Lindsey R Baden
Current Opinion in Virology
Samir K LakhasheRuth M Ruprecht
© 2021 Meta ULC. All rights reserved